One shot, longer effect, just like GLP-1s
Working with a healthcare professional will help you choose the drug that will be most effective for you, given your medical history, existing medications, and other health issues
The company further claims day-long coverage from a design that resists rapid enzymatic breakdown, with an extended activity window described as roughly 24 to 48 hours in preclinical work
Zaher Nuwayhid, director of the Conway Medical Center Weight Loss Program, the expanded access reflects a growing understanding that obesity deserves the same medical attention as other chronic diseases
Why Dose Escalation and Monitoring Matter GLP-1 medications are intentionally started at lower doses and increased gradually over time
Ultimately, the obesity market will likely develop in a complex and unpredictable way, which will likely include both subcutaneous and oral products and combinations, with patients seeking cleaner side-effect profiles and becoming more averse to the ever-more publicized risks